Propensity score-based approaches to confounding by indication in individual patient data meta-analysis: non-standardized treatment for multidrug resistant tuberculosis
| dc.contributor.author | Fox, Gregory J. | en_ZA |
| dc.contributor.author | Benedetti, Andrea | en_ZA |
| dc.contributor.author | Mitnick, Carole D. | en_ZA |
| dc.contributor.author | Pai, Madhukar | en_ZA |
| dc.contributor.author | Menzies, Dick | en_ZA |
| dc.contributor.author | The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB | en_ZA |
| dc.date.accessioned | 2017-09-20T12:25:38Z | |
| dc.date.available | 2017-09-20T12:25:38Z | |
| dc.date.issued | 2016 | |
| dc.description | CITATION: Fox, G. J., et al. 2016. Propensity score-based approaches to confounding by indication in individual patient data meta-analysis: non-standardized treatment for multidrug resistant tuberculosis. PLoS ONE, 11(3):e0151724, doi:10.1371/journal.pone.0151724. | |
| dc.description | The original publication is available at http://journals.plos.org/plosone | |
| dc.description.abstract | Background: In the absence of randomized clinical trials, meta-analysis of individual patient data (IPD) from observational studies may provide the most accurate effect estimates for an intervention. However, confounding by indication remains an important concern that can be addressed by incorporating individual patient covariates in different ways. We compared different analytic approaches to account for confounding in IPD from patients treated for multi-drug resistant tuberculosis (MDR-TB). Methods: Two antibiotic classes were evaluated, fluoroquinolones—considered the cornerstone of effective MDR-TB treatment—and macrolides, which are known to be safe, yet are ineffective in vitro. The primary outcome was treatment success against treatment failure, relapse or death. Effect estimates were obtained using multivariable and propensity-score based approaches. Results: Fluoroquinolone antibiotics were used in 28 included studies, within which 6,612 patients received a fluoroquinolone and 723 patients did not. Macrolides were used in 15 included studies, within which 459 patients received this class of antibiotics and 3,670 did not. Both standard multivariable regression and propensity score-based methods resulted in similar effect estimates for early and late generation fluoroquinolones, while macrolide antibiotics use was associated with reduced treatment success. Conclusions: In this individual patient data meta-analysis, standard multivariable and propensity-score based methods of adjusting for individual patient covariates for observational studies yielded produced similar effect estimates. Even when adjustment is made for potential confounding, interpretation of adjusted estimates must still consider the potential for residual bias. | en_ZA |
| dc.description.uri | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0151724 | |
| dc.description.version | Publisher's version | |
| dc.format.extent | 19 pages | |
| dc.identifier.citation | Fox, G. J., et al. 2016. Propensity score-based approaches to confounding by indication in individual patient data meta-analysis: non-standardized treatment for multidrug resistant tuberculosis. PLoS ONE, 11(3):e0151724, doi:10.1371/journal.pone.0151724 | |
| dc.identifier.issn | 1932-6203 (online) | |
| dc.identifier.other | doi:10.1371/journal.pone.0151724 | |
| dc.identifier.uri | http://hdl.handle.net/10019.1/102265 | |
| dc.language.iso | en_ZA | en_ZA |
| dc.publisher | Public Library of Science | |
| dc.rights.holder | Authors retain copyright | |
| dc.subject | Multidrug-resistant tuberculosis | en_ZA |
| dc.subject | Tuberculosis -- Patients -- Treatment | en_ZA |
| dc.subject | Clinical indications | en_ZA |
| dc.subject | Meta-analysis | en_ZA |
| dc.title | Propensity score-based approaches to confounding by indication in individual patient data meta-analysis: non-standardized treatment for multidrug resistant tuberculosis | en_ZA |
| dc.type | Article | en_ZA |